Porcelain Etch Gel
Belport Company, Inc., Gingi-Pak · Decision date Apr 10, 2026
What did the FDA decide?
FDA records K260430 as a 510(k) premarket notification, with a decision dated Apr 10, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Dental
- Decision date
- Apr 10, 2026
Regulatory record facts
- Identifier
- K260430
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Belport Company, Inc., Gingi-Pak
- Product code
- KLE
- Decision code
- SESE
- Decision date
- Apr 10, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Agent, Tooth Bonding, Resin.
- Applicant
- Belport Company, Inc., Gingi-Pak
- Product code
- KLE
- FDA device class
- 2
FDA decision timeline
K260430 received
Application receipt date recorded by FDA.
K260430 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code KLE
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Dent4You AG | 510(k) clearance | Oct 8, 2026 | FDA | |
MPa Max adhesiveK262252 | Den-Mat Holdings, LLC | 510(k) clearance | Sep 24, 2026 | FDA |
Any-EtchK260485 | Mediclus Co., Ltd. | 510(k) clearance | May 14, 2026 | FDA |
Adhese 2K252450 | Ivoclar Vivadent, Inc. | 510(k) clearance | Mar 5, 2026 | FDA |
Bond-PR Universal AdhesiveK260682 | Premier Dental Products Company | 510(k) clearance | Mar 3, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Belport Company, Inc., Gingi-Pak
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Camarillo, CA
Sources and methodology
- Original FDA record: K260430
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



